Income level and regional policies, underlying factors associated with unwarranted variations in conservative breast cancer surgery in Spain

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Ridao López, Manuel ^a,b   García Armesto, Sandra ^a   Abadía Taira, Begoña ^a   Peiró Moreno, Salvador ^b   Bernal Delgado, Enrique ^a  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^b Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EDUCATION; FEMALE; GEOGRAPHY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INCOME; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL PRACTICE; PARTIAL MASTECTOMY; SOCIAL STATUS; SPAIN; TUMOR VOLUME; BREAST TUMOR; MIDDLE AGED; SEGMENTAL MASTECTOMY; SOCIAL CLASS; STATISTICAL MODEL; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HEALTH POLICY; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MODELS, STATISTICAL; SOCIAL CLASS; SPAIN;

EID: 79955120583     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-145     Document Type: Article

References (39)

1. López-Abente G, Pollán M, Aragonés N, Pérez-Gómez B, Hernández V, Lope Carvajal V, et al. La situación del cáncer en España. 2005, Madrid: Ministerio de Sanidad y Consumo.
2. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R, . EUROCARE Working Group EUROCARE-4. Survival of cancer patients diagnosed. in 1995-1999. Results and commentary. Eur J Cancer 2009, 45:931-99. 10.1016/j.ejca.2008.11.018, 19171476, EUROCARE Working Group.
3. Arriagada R, Lê MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996, 14:1558-64.
4. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-41. 10.1056/NEJMoa022152, 12393820.
5. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-50. 10.1093/jnci/92.14.1143, 10904087.
6. Veronesi U, Cacinelli N, Mariano L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-32. 10.1056/NEJMoa020989, 12393819.
7. Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB. Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 2002, 40:181-9. 10.1097/00005650-200203000-00002, 11880791.
8. Mandelblatt JS, Kerner JF, Hadley J, Hwang YT, Eggert L, Johnson LE, et al. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white. Cancer 2002, 95:1401-14. 10.1002/cncr.10825, 12237908.
9. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 1992, 326:1102-7. 10.1056/NEJM199204233261702, 1552911.
10. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll of Surg 2009, 209:425-33.
11. van Nes JGH, Seynaeve C, Jones S, Markopoulos C, Putter H. van de Velde CJH on behalf of the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trialists Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. British Journal of Surgery 2010, 97:671-679. 10.1002/bjs.6962, 20393978.
12. Librero J, Peiró S, Bernal-Delgado E, Allepuz A, Ridao M, Martínez N. Metodología del Atlas de variaciones en hospitalizaciones por cirugía oncológica en el Sistema Nacional de Salud. Atlas Var Pract Med Sist Nac Salud 2009, 6:274-82.
13. La Caixa Economic Yearbook for Spain. 2005, Accessed 19-6-2010, La Caixa., http://www.anuarieco.lacaixa.comunicacions.com/java/X?cgi=caixa.le_RightMenuHemeroteca.pattern
14. Survey of Inpatient Centres 2003 (ESCRI) Ministry of Health and Social Policy. 2010, Accessed 19-6-2010, Survey of Inpatient Centres 2003., http://pestadistico.msc.es
15. Ibáñez B, Librero J, Bernal-Delgado E, Peiró S, López-Valcarcel BG, Martínez N, et al. Is there much variation in variation? Revisiting statistics of small area variation in health services research. BMC Health Serv Res 2009, 9:60. 10.1186/1472-6963-9-60, 2676262, 19341469.
16. Stoyanova A, Rodríguez M, Pinilla J. El mapa de las desigualdades en salud por grupos de edad en España. Cuadernos Económicos de ICE 2009, 75:21-42.
17. Wagstaff A, Paci P, van Doorslaer E. On the measurement of inequality in health. Soc Sci Med 1991, 33:545-57. 10.1016/0277-9536(91)90212-U, 1962226.
18. Merlo J, Chaix B, Yang M, Lynch J, Råstam L. A brief conceptual tutorial on multilevel analysis in social epidemiology: interpreting neigbourhood differences and the effect of neighbourhood characteristics on individual health. J Epidemiol Community Health 2005, 59:1022-1029. 10.1136/jech.2004.028035, 1732971, 16286487.
19. StataCorp Stata Statistical Software: Release 10. 2007, College Station: TX: StataCorp LP, StataCorp.
20. Araar A, Duclos JI, . DASP Distributive Analysis Stata Package. 2009, Université Laval, PEP, CIRPÉE and World Bank, DASP.
21. Dartmouth Atlas of Health Care Hanover NH:The Center for the Evaluative Clinical Sciences at Dartmouth Medical School. Available at. 2000, (Data on-line), Dartmouth Atlas of Health Care., http://www.dartmouthatlas.org/downloads/reports/effective_care.pdf
22. Oliva G, Allepuz A, Kotzeva A, Tebé C, Bernal-Delgado E, Peiró S. Variaciones en hospitalizaciones por cirugía oncológica en el Sistema Nacional de Salud. Atlas Var Pract Med Sist Nac Salud 2009, 6:241-72.
23. Asua J. Mamografía y detección precoz del cáncer de mama. Rev Esp Salud Pública 2005, 79:517-20.
24. Castells X, Sala M, Ascunce N, Salas D, Zubizarreta R, Casamitjana M. Descripción del cribado del cáncer en España. Proyecto DESCRIC. Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Agència d'Avaluació de Tecnologia i Recerca Mèdiques de Cataluña. AATRM Núm.2006/01 2006,
25. Rubio IT, Marco V. La importancia de los márgenes quirúrgicos en la cirugía conservadora en el cáncer de mama. Cir Esp 2006, 79:3-9. 10.1016/S0009-739X(06)70807-7, 16426527.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-51. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z, 10649300.
27. National Cancer Institute Research and Applications Branch. Joint point trend analysis software. Accessed 19-6-2010, National Cancer Institute., http://surveillance.cancer.gov/software/
28. Tebé C, Márquez-Calderón S, Benitez JR, Sánchez-Lanuza M, Fernández R, Aguado MJ. Estado actual de la cirugía oncológica de mama en Andalucía y Cataluña. Cir Esp 2009, 86:369-77. 10.1016/j.ciresp.2008.09.022, 19800055.
29. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002, 137:511-20.
30. Nattinger AB, Laud PW, Sparapani RA, Zhang X, Neuner JM, Gilligan MA. Exploring the surgeon volume outcome relationship among women with breast cancer. Arch Intern Med 2007, 167:1958-63. 10.1001/archinte.167.18.1958, 17923595.
31. Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, et al. Surgeon perspectives about local therapy for breast carcinoma. Cancer 2005, 104:1854-61. 10.1002/cncr.21396, 16161056.
32. Keating NL, Weeks JC, Borbas C, Guadagnoli E. Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed?. Breast Cancer Res Treat 2003, 79:225-31. 10.1023/A:1023903701674, 12825857.
33. Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009, 302:1551-6. 10.1001/jama.2009.1450, 19826024.
34. Molenaar S, Oort F, Sprangers M, Rutgers E, Luiten E, Mulder J, et al. Predictors of patients choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer 2004, 90:2123-30. 2409497, 15150557.
35. Polsky D, Keating NL, Weeks JC, Schulman KA. Patient choice of breast cancer treatment: impact on health state preferences. Med Care 2002, 40:1068-79. 10.1097/00005650-200211000-00008, 12409852.
36. Bernal-Delgado E, Martos C, Martínez N, Chirlaque MD, Márquez M, Navarro C, et al. Is hospital discharge administrative data an appropriate source of information for cancer registries purposes? Some insights from four Spanish registries. BMC Health Serv Res 2010, 10:9. 10.1186/1472-6963-10-9, 2836319, 20059773.
37. Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F, et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conservating procedures: results of EORTC trial 1081. Eur J Cancer 1998, 34:307-14. 10.1016/S0959-8049(97)00312-2, 9640214.
38. McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, et al. Surgical management of early stage invasive breast cancer: a practice guideline. Can J Surg 2005, 48:185-94.
39. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, et al. Quality of life after breast cancer surgery: What have we learned and where should we go next?. J Surg Oncol 2009, 99:447-55. 10.1002/jso.21151, 19418493.